Chemours Company (The) (CC) Stock

About Chemours Company (The)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Chemours Company (The) (CC) stock trades at $12.81 with a market capitalization of $1.93B. The stock is valued at a negative price-to-earnings (P/E) ratio of -6.37, reflecting a net loss over the last twelve months, a negative price-to-book of -39.36, reflecting negative shareholders' equity, price-to-sales of 0.33. Over the past 52 weeks the stock has ranged between $10.44 and $28.67, and currently trades 55.3% below its 52-week high. It pays a dividend yielding 2.75%.

On profitability, Chemours Company (The) generates a return on equity (ROE) of -170.31% (not meaningful, as shareholders' equity is negative), return on capital employed of -5.75%, an operating margin of -0.33%, a net profit margin of -5.24%.

Official website: www.chemours.com

Chemours Company (The) by the numbers, 2016–2025

Between 2016 and 2025 Chemours Company (The) reported revenue of $5.4B rising to $5.8B, a change of +7.6% across 10 years. Compounded, revenue has grown 3.2% a year over five years, -5.3% over three, 0.5% over the last twelve months. Net profit fell to $-386.0M.

Operating margin went from 1.8% in 2016 to -0.1% in 2025, a fall of 1.9 percentage points. The most recent net margin is -5.24%. On a trailing twelve-month basis to Jun '26, revenue is $5.8B and net profit $-304.0M.

Borrowings rose from $3.5B to $4.6B, cash on hand is $671.0M, cash from operations was $264.0M in the latest year, positive in 9 of the last 10.

Return on equity has averaged -12.8% over five years, and was -154.4% in the most recent year.

The share price itself has compounded at -6.2% a year over five years, -9.6% over three, 109.3% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Chemours Company (The) (CC) — frequently asked questions